Axa
REVB icon

Axa’s Revelation Biosciences REVB Stock Holding History

Axa’s Portfolio REVB Stock Details REVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10
Closed -$27.5K – 1108
2023
Q4 		$27.5K Hold
10
– – ﹤0.01% 1055
2023
Q3 		$38.6K Hold
10
– – ﹤0.01% 1049
2023
Q2 		$52.6K Hold
10
– – ﹤0.01% 1064
2023
Q1 		$72.8K Hold
10
– – ﹤0.01% 1085
2022
Q4 		$372K Hold
10
– – ﹤0.01% 1024
2022
Q3 		$512K Hold
10
– – ﹤0.01% 962
2022
Q2 		$2.17M Hold
10
– – 0.01% 758
2022
Q1 		$2.23M Buy
+10
New +$6.38M 0.01% 810

Other funds holding REVB

UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
PIS
POM Investment Strategies Raleigh, North Carolina $80.5M AUM 16.64% 1-Year Est. Return